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The respiratory condition COVID-19 arises in a human host upon the infection with
SARS-CoV-2, a coronavirus that was first acknowledged in Wuhan, China, at the end
of December 2019 after its outbreak of viral pneumonia. The full-blown COVID-19
can lead, in susceptible individuals, to premature death because of the massive viral
proliferation, hypoxia, misdirected host immunoresponse, microthrombosis, and drug
toxicities. Alike other coronaviruses, SARS-CoV-2 has a neuroinvasive potential, which
may be associated with early neurological symptoms. In the past, the nervous tissue of
patients infected with other coronaviruses was shown to be heavily infiltrated. Patients
with SARS-CoV-2 commonly report dysosmia, which has been related to the viral access
in the olfactory bulb. However, this early symptom may reflect the nasal proliferation
that should not be confused with the viral access in the central nervous system of the
host, which can instead be allowed by means of other routes for spreading in most
of the neuroanatomical districts. Axonal, trans-synaptic, perineural, blood, lymphatic, or
Trojan routes can gain the virus multiples accesses from peripheral neuronal networks,
thus ultimately invading the brain and brainstem. The death upon respiratory failure may
be also associated with the local inflammation- and thrombi-derived damages to the
respiratory reflexes in both the lung neuronal network and brainstem center. Beyond the
infection-associated neurological symptoms, long-term neuropsychiatric consequences
that could occur months after the host recovery are not to be excluded. While our article
does not attempt to fully comprehend all accesses for host neuroinvasion, we aim at
stimulating researchers and clinicians to fully consider the neuroinvasive potential of
SARS-CoV-2, which is likely to affect the peripheral nervous system targets first, such
as the enteric and pulmonary nervous networks. This acknowledgment may shed some
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light on the disease understanding further guiding public health preventive
efforts and medical therapies to fight the pandemic that directly or indirectly
affects healthy isolated individuals, quarantined subjects, sick hospitalized, and
healthcare workers.
Keywords: smell, olfactory bulb, coronavirus, SARS-CoV-2, COVID-19, infections, virulence, host pathogen
interactions
THE SNIFFING OUT OF CORONAVIRUSES
Named after their crown-like spikes, coronaviruses are large
non-segmented single-stranded positive-sense enveloped RNA
viruses that may spill out from animals to infect humans and
cause respiratory diseases. In 2003, the Severe Acute Respiratory
Syndrome (SARS-CoV-1) spilled out from civet cats (Ksiazek
et al., 2003) and, in 2012, the Middle East Respiratory Syndrome
(MERS-CoV) spilled out from camels (Zaki et al., 2012). At
the end of December 2019, a new strain of familial coronavirus
(SARS-CoV-2) caused an outbreak of viral pneumonia inWuhan,
Hubei province in China, but the animal source is still under
investigation (probably bats). Similarly to -or even better than-
its most closely relative SARS-CoV-1 (Shang et al., 2020), this
strain uses the angiotensin-converting enzyme 2 (ACE2) as
its host receptor to enter targeted cells and to replicate and
infect adjacent cells. The ubiquitous presence of this receptor
is associated with the systemic affections of COVID-19 (Patel
and Verma, 2020). Infected patients experience mild to severe
systemic, respiratory, and enteric manifestations, such as fever,
myalgia, lethargy, dry cough, dyspnoea, anorexia, abdominal
pain, and diarrhea. Transmission is mainly by human respiratory
droplets carrying the virus, which enters the airways of the
host and infects epithelial cells (Zhu et al., 2020). However,
there is the need to further investigate the mode of SARS-
CoV-2 transmission and its early and late symptoms, as a
matter of disease understating and human conservation. New
information comes out every day that could radically change
the understanding of the viral nature of the disease, such as the
susceptibility of domestic animals to contagion (Shi et al., 2020)
or the role of pollution for viral spreading (Setti et al., 2020).
The environmental stability of SARS-CoV-2 is similar to that
of SARS-CoV-1 (van Doremalen et al., 2020), indicating that
differences in the epidemiologic characteristics of these viruses
probably arise from other factors, including the contagion from
infected individuals that are unaware because asymptomatic (Bai
et al., 2020).
On March 21st, the British Association of
Otorhinolaryngology released a statement that dysosmia could
be associated with SARS-CoV-2 contagion (Hopkins and Kumar,
2020), highlighting the possibility of the nasal-nervous route as
alternative access of the virus (Baig et al., 2020). Interestingly, a
report of April 1st from King’s College London researchers stated
that 59% of infected individuals participating in their survey
reported dysosmia or dysgeusia (COVID-19_SymptomTracker,
2020). Still, most of the beliefs are anecdotal and not evidence-
based. Contrariwise, strong evidence supports the notion that
respiratory viruses are neurotropic and can access the central
nervous system via peripheral nerves, including the olfactory
bulb (Mori et al., 2005; van Riel et al., 2015). SARS-CoV-2 shares
similar infection pathways compared to its predecessors and
therefore the infection mechanisms previously found for other
coronaviruses may also be applicable for this new strain. It is
urgent to discuss whether SARS-CoV-2 can gain access to the
central nervous system through a nasal-nervous pathway or
other routes and if the fatal respiratory failure may be associated
with a neuronal injury in critical brain areas of the host.
THE SNIFFING PROBLEMS
It is believed that the distribution of the targeted host receptor
in tissues is consistent with the tropism of the infective agent
(To and Lo, 2004). The receptor ACE2 is expressed primarily in
human airway epithelia, lung parenchyma, and small intestine
cells, but also in the heart, kidney, and nervous tissues. Despite
the ACE2 pathway possibly being not the only one preferred by
the virus, the receptor itself is located in the brainstem, being
particularly expressed in the cardiorespiratory center (Xia and
Lazartigues, 2008). Other than the receptor distribution, two
other factors have to be considered when referring to the viral
tropism: the path of contagion and the host’s abilities to fight the
infective agents, which might function as a double-edged sword.
Themain anatomical district that contacts the SARS-CoV-2 is the
respiratory mucosa and here it is believed to occur the primary
in-host proliferation that may indeed be associated with the
smell disorders. Once inside the human host, the host’s abilities
come into play against the virus, thus allowing the categorization
of SARS-CoV-2-associated insults in two forms: (I) damages
directly associated with viral proliferation (e.g., cytotoxicity) and
(II) damage indirectly associated with host’s infection, being
mainly hypoxia, inflammation (often an overactive host’s ability),
and disseminated intravascular coagulation (Lillicrap, 2020).
That is, three main hypothesis can be advanced regarding the
dysosmia of infected subjects:
• Hypothesis 1: the impairment is caused by the nasal blockage
after the pooling of blood in the capacitance vessels upon viral
upper respiratory infection. Smell impairment is known to
be associated with nasal congestion (Akerlund et al., 1995)
and the mucosal swelling easily impedes the physical access of
odors to the olfactory region.
• Hypothesis 2: olfactory receptors in the neuroepithelium are
disrupted upon excessive local inflammatory responses (Doty
and Mishra, 2001). In fact, it was suggested that the olfactory
function could be independent of nasal congestion, but
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subjected to recovery after the viscous phase onset (Hummel
et al., 1998).
• Hypothesis 3: dysosmia follows a direct viral insult by the virus
because of the peripheral destruction of olfactory receptor
cells (Perlman et al., 1990). If this is the case, it is also
probable that the virus can invade the central nervous system
through the retrograde axonal transport from the olfactory
neuroepithelium and olfactory pathways.
Since SARS-CoV-2 has not been associated with upper
respiratory symptoms (Huang et al., 2020), it seems that the first
two hypotheses can be excluded. The third hypothesis is the most
fascinating, and lately, it has sparked much interest because of
the potential public health implications. Whatever the nature of
dysosmia, it could be difficult to define its underlying etiology
since co-viral infections are very common in the outbreak
season, patients with mild symptoms are rarely tested and, if
admitted to clinics, the concomitant pharyngodynia and fever
may blur a proper anamnesis. If dysosmia had late-onset, patients
might recognize the olfactory loss long after the insult, when
precise identification of the putative cause could be no longer
feasible (Seiden, 2004). Of note, the deficit in olfactory function
after infection should not be permanent instead depend on the
severity of the initial insult (Duncan and Seiden, 1995). In fact,
these neurons are subjected to continual turnover to offer a
large spectrum of computational functions throughout different
developmental and environmental stages (Benito et al., 2018).
Although some authors have observed that the damage to the
olfactory epithelium was also associated with affections in central
olfactory pathways (Mohammed et al., 1990; Yamagishi et al.,
1994), the other possible access routes cannot be ruled out. With
particular emphasis on the nasal cavity as the assumed early route
of the host’s neuroinvasion, we discuss the hypothesis that SARS-
CoV-2 neuroinvasion of various tissues can be considered the
underlying pathway of the virus spreading and associated fatality
of the human host.
THE HUMAN ACCESSES FOR
SARS-COV-2 NEUROINVASION
Unfortunately, SARS-CoV-2 may be not always confined to the
respiratory or gastrointestinal tract, but it may also invade the
annexed nerve tissues. Early studies after the outbreak of SARS-
CoV-1 demonstrated the presence of viral particles in the brain,
where they were located almost exclusively in the neurons. In
light of the high pathophysiological pathway similarity between
SARS-CoV-1 and SARS-CoV-2 (Glass et al., 2004), it is quite
likely they share a similar neuroinvasive potential. Putative routes
for SARS-CoV-2 neuroinvasion can be summarized as follows:
• Neuronal route. SARS-CoV-2 could enter the nervous system
through peripheral nerve fibers, not only including the
olfactory receptors in the nasal epithelium, but also the
pulmonary network and the enteric nervous system.
• Pericellular route. Being extremely important for the infection
of adjacent cells, the extracellular route of major interest for
our discussion is the cleft between the efferents of olfactory
sensory neurons and their ensheathing cells. Other routes
could comprise the diffusion through the mucous layer of the
respiratory tract or the cerebrospinal fluid.
• Hematogenous route. The blood guarantees direct access
to nervous tissues. Specific barriers normally restrict the
spread of viruses into the central nervous system, but direct
infection of the neurovascular unit or the triggering of
neuroinflammation can compromise the integrity.
• Lymphatic route. It can be considered the third widespread
system after the brain-nervous and the cardio-circulatory
networks. Viral particles can infiltrate through the lymphatics
to the lymphoid tissues subsequently infecting cells in close
contact with the blood flow.
• Trojan route. Infected migrating leukocyte can carry
intracellular viruses and then migrate into the central nervous
system. In fact, the infected neuronal cell populations often
recruit non-specific leukocytes to fight the infective agent
(Ransohoff and Engelhardt, 2012), which can be later released
and freed to infect local neuronal cells.
THE JOURNEY OF SARS-COV-2 TOWARD
THE HOST NERVOUS SYSTEM
Nasal Proliferation
In humans, the nasal cavity comprises the anterior vestibule,
the more extensive respiratory epithelium, and the posterodorsal
olfactory epithelium, which comprises distinct cell types and that
houses the olfactory neurons with their non-motile cilia (cranial
nerve I: odors). Underlying the olfactory epithelium is the lamina
propria, which contains blood vessels, lymphatics, branches
of the trigeminal nerve (cranial nerve V: burning, cooling,
irritation, tickling), and the ensheathing cells surrounding the
efferents of olfactory neurons (i.e., fila olfactoria) that cross the
deep cribriform plate. Of note, the trigeminal sensory system
constitutes the largest nervous passage that directly innervates
the brainstem medulla and, among its three branches, it is
important to consider that both the ophthalmic and themaxillary
fiber gets in close contact with potential viral accesses, being
the conjunctiva (Chen et al., 2020b) and the nasal mucosa.
Opportunely, this mucosa has an extensive surface area that
collides with thousands of different particles every day, but
whose access is evaded by tight and adherence junctions.
The disruption of these junctions causes irreversible functional
damages, still without fully being associated with an altered
mucosa permeability (Ganger and Schindowski, 2018). Given
the humidity and temperature of the nasal cavity together with
the stability of SARS-CoV-2, it is plausible that the virus has
the characteristic features of having a good replication rate in
the olfactory mucosa. In fact, higher viral loads of SARS-CoV-
2 were found in the nose compared to the throat (Zou et al.,
2020), and this fact could possibly be associated to the unware
transmission of the virus by asymptomatic individuals. However,
subjects infected with SARS-CoV-2 resulted to be recurrently co-
infected with other respiratory viruses (Conger, 2020), rendering
the identification of smell disorders as an early COVID-19
sign hard to recognize. Any viral particles proliferating in the
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nasal cavity provokes an inflammatory response at the level of
the olfactory epithelium, easily impairing the odor perception
upon mucosal swelling and nasal blockage. Nevertheless, these
events should be accompanied with upper respiratory tract
symptoms, such as rhinorrhea, nasal discharge, or sneezing,
but these symptoms were not reported during SARS-CoV-2
infection nor the attachment viral pattern so far. Even if the
vascular or lymphatic routes have been investigated only for drug
administrations rather than infectious diseases (Veronesi et al.,
2020), it is reasonable to assume that the coronavirus would get
in close contact with these vessels, thus accessing the systemic
circulation. However, the lymphatic network in the nasopharynx
(i.e., the mucosa-associated lymphoid tissue) is in charge of the
immunotolerance and reaction alike in any other tissue. Tonsils,
which project to the surface of submucosal lymphoid tissue
or emerge into the pharynx, and their reticular epithelium are
featured with different cell types including themicrofold cells and
leucocytes. These sites are nevertheless well-patrolled. However,
even if an underlying inflammatory mucosa was not manifested
through clinical signs, it should be considered that the SARS-
CoV-2 affecting the olfactory epithelium could get access not only
to the abovementioned non-nervous tissues but also to a variety
of neuronal routes to access the brain.
Damage to Pulmonary Nerve Fibers
The respiratory system has two though not completely distinct
vascular systems and depends for its function on both local and
systemic sensory receptors, involuntary central processing, and
voluntary breathing, with widespread lymphatic and nervous
networks permeating the airways. In particular, the nerve fibers
comprise those of the vagus nerve and the dorsal root ganglia.
Two important cells are the ciliated that propel the mucus
toward the nasopharynx and the neuroendocrine cells, whose
putative sensor function at the levels of the local airway ganglion
may be involved in the fine-tuning of blood flow in response
to hypoxia (Adriaensen et al., 2003). In fact, both sympathetic
and parasympathetic perivascular nerve fibers extend to small
intrapulmonary vessels and adapt the local vascular impedance
to diverse conditions. The proper endothelial responses and
vascular remodeling in the lungs are known to be highly
dependent on the proper functioning of ACE2 (Li et al.,
2013a), whose expression appears to be increased in smokers
and those with chronic obstructive pulmonary disease (Leung
et al., 2020). The respiratory muscles have also a vital role,
aiding the movement of the thoracic cavity to offer space for
inhalation and air expulsion. Giving the way of contagion,
the host’s receptor, and symptoms upon infection, SARS-CoV-
2 is considered a respiratory virus. Dry cough and dyspnea
arise upon the destruction of epithelial cells of the airways
and host’s local, hence still controlled, immunoresponse. The
potential to affect pneumocytes appears to be a typical feature
of the SARS viruses, with a replicative potential of SARS-CoV-
2 being higher than its predecessor (Chu et al., 2020). The
neuroinvasive potential may be a common denominator as well.
Giving the high innervation of the lungs, the possibility that the
virus may access the nerve fibers of the airways should be of
great concern. Other coronaviruses were shown to be able to
spread to the central nervous system by accessing from dorsal
root ganglia (Li et al., 2012) in parallel with the widespread
blood and lymphatic networks, possibly preferring the circulating
leucocytes as vectors rather than freely migrating in the fluids.
This preference was indeed observed for SARS-CoV-1 (Gu et al.,
2005), which was found in pulmonary macrophages (To et al.,
2004). The alveoli are highly sprayed with blood and represent
the most accessible spot before the endothelial system, where
the pumping flow would ensure the rapid dissemination of
viral particles. If the coronavirus was able to exploit the blood
flow, the infiltration in endothelial or epithelial cells of brain
barriers would be plausible (Desforges et al., 2019). The central
nervous system appears to be accessed by viruses through not
only the hemotogenous, olfactory, trigeminal, or enteric routes.
The nerve fibers in the lungs may be subjected, similarly to the
enteric network, to two affections. First, the viral interference
on critical sensory receptors for the autonomic regulation of
breathing can cause a vagal dysregulation, which is known to
be associated with negative changes in the reflex control of
the airways (e.g., in chronic obstructive pulmonary disease)
(Undem and Kollarik, 2005). Second, like in asthmatic lungs (El-
Chemaly et al., 2008), the immuno- and thrombi-derived lesions
during COVID-19 can easily contribute to progressive lymphatic
damage and alteration in the bronchial circulation that impair
the nutrient-waste balance for the walls of the larger airways.
The respiratory difficulties may require increased involvement
of accessory muscles, with the progressive mental and physical
exhaustion, hypoxemia, and pulmonary injury. Patients infected
with SARS-CoV-2 showed increased circulating levels of IL-6,
which could originate from the infected epithelial cells of the
lungs (Zhang et al., 2004). Importantly, the systemic flows of
this cytokine have been associated with glial cell activation, brain
injury, and infiltrated leukocytes (Zhang et al., 2015; Rothaug
et al., 2016), which may indeed offer the ideal Trojan horse while
the host’s immune system is committed to counteracting the
cytokine flow.
Enteric Nervous System Invasion
A single, multi-component (Vergnolle and Cirillo, 2018),
epithelial barrier of cells protects the host against the xenobiotics
located in the gut and intercellular junctions tightly seal the
space in-between cells. The gut-associated lymphoid tissue with
the mesenteric lymph nodes and the microfold cells are in
charge of the sampling, phagocytosis, and transcytosis of luminal
molecules, viruses, bacteria, parasites, and dietary supplements
(Briguglio et al., 2020a), being critical for the first-line immune
responses of the host (Mabbott et al., 2013). That is, SARS-CoV-
2 faces a dual obstacle represented by both the physical barrier
and the immune barrier before being able to fully affecting the
enterocytes. However, the virus may be driven by the extensive
presence of its host receptor, the ACE2, whose expression in the
gut reflects the dual role in mediating both the viral infiltration
and the host’s immunocompetence against the manifestations
of COVID-19 (Wang et al., 2020). Most of the aspects of gut
functions are controlled by the enteric nervous system, which
comprises a network of neuronal cells deep in the wall of the
bowel, with the proper homeostatic synchrony being guaranteed
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by the communication with the intestinal epithelium, dietary
factors, the microbiota, and the mucosal immune system. The
central nervous system is directly connected to the enteric
neuronal network mainly through the parasympathetic vagus
nerve that arises from the hindbrain and the sympathetic nerve
fibers that arise from the spine, with the main neurotransmitters
being acetylcholine and the catecholamines, respectively. The
possibility of a fecal-oral transmission for SARS-CoV-2 has not to
be excluded (Yeo et al., 2020) as it can be found in stool samples of
infected patients alike SARS-Co-V-1 and MERS-CoV (Shi et al.,
2005; Corman et al., 2016; Holshue et al., 2020), with commonly
referred gastrointestinal symptoms being abdominal pain or
diarrhea. The neuroinvasive potential of coronaviruses could be
reflected by the absence of tissue destruction or inflammatory
lesions in the intestines of infected patients with SARS-CoV-
1 (To et al., 2004), thus possibly suggesting the propensity of
coronaviruses to possess a targeting pattern capable to avoid
eliciting host’s immunoresponses that could compromise the
viral invasion at the early steps. Alike the infiltration in the
peripheral nerve endings of the olfactory system, coronaviruses
were shown to be capable to invade the central nervous system
also by making use of alternative peripheral pathways through
the spinal cord (Li et al., 2013b). The presence of the virus in the
gut may be due to the self-ingestion of mucus from the airways
(Li et al., 2020a). Undeniably, the enteric invasion can affect
both the lymphatic and blood networks. Hypoxic conditions
in COVID-19 patients can easily impair the proper regulation
of the trafficking via lymphatic vessels, further contributing to
increasing the inflammatory condition (Miller et al., 2010). The
excessive infected lymphatic return to the general circulation for
degradation in the liver may have a role in the liver damage
observed in COVID-19 patients, other than the virus-induced
cytotoxicity of T cells and the cytokine flow (Bangash et al.,
2020). Moreover, the fine-tuning of the nervous reflex arcs that
regulate important gastrointestinal functions, such as the fluid
exchange, may be also impeded (Yoo and Mazmanian, 2017).
Microthrombosis was indeed found in multiple organs (Zhou
et al., 2020). It is important to consider that the eventual gut
invasion by SARS-CoV-2 and the subsequent vagal affection
could disturb not only the local abovementioned functions but
also compromise the immunotolerance (Rosas-Ballina et al.,
2008; Costes et al., 2013) and reaction (Rosas-Ballina et al.,
2011) of the host. Of note, the impairing of the sympatho-vagal
control may be a critical factor affecting the proper brainstem
functioning in severe COVID-19.
Olfactory Bulb Infiltration
The axons of olfactory receptor cells that pass the cribriform
plate contact the second-order neurons of the olfactory bulb
within the spherical glomeruli. This route currently represents
the most discussed around the reported dysosmia of patients
infected with the coronavirus. In fact, this hypothesis, which we
previously raised as the Hypothesis 3, implies that SARS-CoV-
2 is able to infiltrate in the olfactory bulb, possibly traveling
through neuronal cells (transneuronally) or around neuronal
cells (perineurally) to enter the brain. Most of the studies that
showed the possibility of a central nervous system infiltration
from the nasal-nervous route were performed on mice, which
have very important differences in the olfactory system (McGann,
2017). For instance, the bulbs of rodents are large and positioned
prominently at the very front of the cerebrum whereas the
counterparts in humans are proportionally smaller, flattened,
and positioned underneath the frontal lobe. Humans lack the
accessory olfactory system, have 8-fold the number of glomeruli
processing inputs from each receptor type compared to rodents,
and possess more elaborate orbitofrontal cortical regions for
interpreting odor inputs. It is vital to ponder the anatomy
of the olfactory bulb and the different viral tropism across
species. For instance, some authors reported different infiltration
mechanisms for the same drug between humans and rodents,
being the bulk flow (perineural route) for the first and the
rostral migratory stream (transneuronal route) for the second
(Lochhead et al., 2015). It should be also considered that
the diverse microcircuitry and structure of the olfactory bulb
between males and females (Oliveira-Pinto et al., 2014) may have
a role in the nasal proliferation and nervous-access. Pioneering
studies supporting the olfactory bulb infiltration started in the
first half of the twentieth century (Faber and Gebhardt, 1933)
and the first human reports about a possible olfactory affection
by SARS-CoV-1 came out 3 years after the 2003 outbreak
(Hwang, 2006). From there on, clinicians and researchers posed
much more attention to the possible neuroinvasive feature of
viruses, mostly due to the potential fatal consequences upon
infection of critical brain areas, such as the brainstem or the
thalamus. Undeniably, SARS-CoV-1 was found in both regions
after being intranasally injected in laboratorymice (McCray et al.,
2007). This possibility should arise concern as much as that
offered by adjacent nerves. Trigeminal branches could allow a
similar retrograde (toward the soma) and anterograde (toward
the synapse) axonal transport toward the brain. However,
the transitive relationship between nasal injection and brain
infiltration does not assume that the nasal-nervous route is the
putative pathway. The transneuronal pathway implies that the
virus is endocytosed and transported in endocytic vesicles along
the nerve fibers until reaching of the synaptic cleft in the olfactory
bulb. The subarachnoid space may be reached here given its
adjacent position to the olfactory bulb. However, in order to
travel through the olfactory pathway the envelope of SARS-CoV-
2 should be stable all along with the neuronal transport. The
induction of apoptosis of infected olfactory receptors is in fact a
well-known defensemechanism to prevent anterograde transport
of pathogens (Mori et al., 2002). Some authors reported cases
of encephalopathy with no respiratory manifestations after the
contagion with influenza (de Jong et al., 2005; Simon et al., 2013).
Is it possible that the coronavirus was so virulent that it entered
the central nervous system directly without passing through the
airways? Collateral damages from the cytokine flow are known
to elicit a sequela of neuroendocrine immunoreactions in the
infected host (Silverman et al., 2005), which if not properly
controlled could cause permanent damages (Chen et al., 2020a).
The inflammatory-derived disruption of the olfactory epithelium
may not only allow SARS-CoV-2 to proliferate in the lamina
propria, but it could also alter the local milieu for proper
nervous homeostasis (Steinke et al., 2008), thus allowing the
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virus to access the central nervous system perineurally through
the diffusion in the cleft between the fila olfactoria and their
ensheathing cells. These bulk flow processes imply that junctions
between cells are more porous than normal, which may be due to
either local inflammation or rapid turnover of olfactory neurons
that leave a gap after their death. The time between cell death
and the repositioning of a new olfactory sensory neuron may
be sufficient to allow SARS-CoV-2 passage, especially if the viral
load was very high in the nasal mucosa. The virus could even use
the time it takes for new tight junctions to form (Lochhead and
Thorne, 2012). The absorption into blood vessels or lymphatics
connected to the cervical nodes may be parallel routes as well.
Brain Infiltration
The brain serves any possible function in humans and, for
the most part, remains separate from the other systems of the
body, which keeps under control with the extensive network
of nerve fibers. Unfortunately, neuronal cells express the entry
protein ACE2 and therefore represent a predefined goal during
the progressive SARS-CoV-2 host invasion. Since the trigeminal
nerve is the highway among nervous routes -particles up to
100 nm can enter the brain via this route (Oberdorster et al.,
2004)-, it is likely that SARS-CoV-2 uses it as the nervous route. It
is used also by bacteria to target central nervous system areas (St
John et al., 2016) and it represents a delivery system of interest for
far smaller drugs (Crowe et al., 2018). In the past, different viruses
that shared the common nasal cavity as access site were observed
to follow distinct noradrenergic, dopaminergic, or serotoninergic
pathways (Barnett et al., 1993; McLean et al., 1993). Indeed, is
also the terminal nerve (cranial nerve 0: hormonal responses)
that running medially to the olfactory tract enters the brain
independently. There is no current report that ever investigated
its role in host contagion, but the observed dysosmia in infected
patients may recall the smell disorders typical of the Kallmann
syndrome, in which the terminal nerve could play a critical role
in terms of hormonal disruption (Taroc et al., 2017). Importantly,
the affection of the terminal nerve may affect the hypothalamus-
pituitary-adrenal axis (Sonne and Lopez-Ojeda, 2020), thus
further compromising the host’s immunocompetence. Other
than severe acute respiratory viruses, also prototype human
coronaviruses, such as OC43 and 229E, had been found in
the cerebrum (Dube et al., 2018). There are plenty of possible
mechanisms that can be used by viruses to colonize the brain
parenchyma, naming the trans-synaptic transport, microfusion
of two adjacent neuronal cells, actin tails, or many others (van
Riel et al., 2015). It is likely that SARS-CoV-2 is capable to make
use of one of these (Steardo et al., 2020), but the fact that it can
be transferred between neurons is of major concern (Li et al.,
2020b). Cases of encephalitis and acute flaccid paralysis had been
reported not only from the well-known endemic coronaviruses
(Turgay et al., 2015; Morfopoulou et al., 2016), but also for SARS-
CoV-2 (Ye et al., 2020; Zhao et al., 2020). Viral agents are known
to possibly reach the cerebrospinal fluid by diffusing under the
ensheathing cells of the fila olfactoria (Li et al., 2005; Bodewes
et al., 2011). Whether via this perineural route or nervous-
connected pathways, after initial infection with SARS-CoV-2
maybe it is not as important as it gets to the brain, the problem
is that it gets there. SARS-CoV-1 was found in brain tissues (Xu
et al., 2005), showing necrotic neuronal damages, widespread
gliosis, and leukocyte infiltration in the brain mesenchyme. Once
in the brain, SARS-CoV-2 is likely to cause similar damages.
Conversely, if SARS-CoV-2 could have not entered the brain,
then the brain congestion, edema, and neuronal degeneration,
which have been found in patients infected with SARS-CoV-
2 (Zhou et al., 2020), would have been due to other causes.
The cerebrospinal fluid that recirculates through the brain
forms the glymphatic system together with the interstitial fluid
(Nedergaard, 2013), and currently represent the main topic of
interest that undermines the dogma regarding brain tolerance
and the immune privilege. Several points of communication
give access to the central nervous system, comprising the
circumventricular organs (e.g., the median eminence and the
subfornical organ), which are in contact with the bloodstream,
and the meninges and cerebrospinal fluid, which are in contact
with the lymphatics (Louveau et al., 2015). The openings between
the blood circulation and the brain parenchyma usually allow
the access of circulating signaling molecules important for
monitoring the periphery, but they also permit the passage of
cytokines and infective agents, exposing local neural and non-
neuronal cells. Neurological damages are likely caused by the
virus-induced inflammatory responses and hypoxic conditions
typical of COVID-19. The largest pial vessels and smallest
brain capillaries allow the virus to spread, and injuries to the
lymphatic system may lead to the accumulation of toxic waste
products. Microglial cells that reside in the brain are capable
of phagocytosis and cytotoxic mechanisms that destroy foreign
particles, unfortunately eliciting a cytokine flow that opens the
blood-brain barrier (Yin et al., 2017). Gliosis and glial cell
apoptosis is accompanied by the infiltration of leucocytes from
the perivascular region to the brain parenchyma where infected
neuronal cells reside. If persistently-infected by SARS-CoV-2,
these immune cells could serve as a reservoir and Trojan horse
for neuroinvasion that increases the viral load.
Brainstem Infiltration
The brainstem comprises many important structures critical
for a variety of functions, such as body temperature and
cardio-respiratory automation, and it is in charge of integrating
humoral, neuronal, and physical responses, such as nausea
and vomiting upon toxin detection. In particular, the medulla
oblongata drives the respiration with sensorial outputs from
metabolic receptors -mostly vascular- and mechanoreceptors-
mostly pulmonary- further adjusting the inspiration and
expiration. An important convergence point of many neural
pathways at the level of the brainstem is the solitary tract, which
is a myelinated fiber bundle that connects the trigeminal nerve
rostrally and the vagus nerve caudally, being the initial relay
for pulmonary receptors. Among the circumventricular organs,
the area postrema is an important local site that allows the
touching of circulating substances with the brain parenchyma
(Briguglio et al., 2018). Brainstem infiltration of viral agents is
known to be associated with medulla oblongata invasion and
worst neurological consequences, such as neurogenic pulmonary
edema (Davison et al., 2012). The brainstem was shown
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to be highly infected by both SARS-CoV-1 (Netland et al.,
2008) and MERS-COV (Li et al., 2016). Hence, its widespread
anatomical interconnections render the brainstem a coveted
and easily invaded prey even for SARS-CoV-2, which was
indeed found in the cerebrospinal fluid (Sun and Guan, 2020)
and therefore suggested to directly or indirectly affect the
cardiorespiratory center in critically ill COVID-19 patients. It
is not clear which nervous routes are preferred by neurotropic
viruses to access the brainstem, but both the cranial nerves
and the motor components of spinal nerves were shown to
be feasible (Tan et al., 2014). As we mentioned above, two
types of damages are associated with SARS-CoV-2 infection,
but much of the neuropathology may be associated with
the host’s inflammatory response to the viral infection. Being
connected to putative nervous routes of access, the solitary
tract may be the intersection that causes direct brainstem
infiltration and the cascade of systemic consequences. If we
assume the early invasions of pulmonary nerve fibers, then
sensory information that the nucleus of the solitary tract receives
would be artificial. The SARS-CoV-2 is known to trigger a
substantial systemic inflammatory storm with a subsequent
significant break of the blood-brain barrier. Following the sequela
of neuronal damages that have been discussed after brain
infiltration, we know that the inflammation-derived impairment
of cerebral microcircuitry in the brainstem, the necrotizing
leukoencephalopathy, the neuronal apoptosis of autonomic
nuclei, and electrolyte disturbances are all features that can
further impede a proper brainstem functioning. Of note, these
manifestations, at different levels of severity, are typical of septic
conditions (Benghanem et al., 2020) and therefore likely to
occur in severe COVID-19 patients. Unfortunately, these subjects
are often under anesthesia, which is known to increase the
glymphatic fluxes (Xie et al., 2013), possibly favoring the Trojan
route (Stamatovic et al., 2005). The circulating cytokines that
get in close contact with the area postrema could further affect
the vagal signals together with the bulbospinal pathway that
drives the automation of respiratory muscles. The more severe
are the brainstem lesions the more complicated would be the
ventilator management of critically ill patients. It is therefore
conceivable that a brainstem-related neuro-immune impairment
upon SARS-CoV-2 contagion can contribute to higher viral loads
in critical neuroanatomical districts, multiple organ dysfunction,
immunoincompentence, and fatal consequences.
NEUROLOGICAL AND PSYCHIATRIC
IMPLICATIONS OF THE SARS-COV-2
Neuropsychiatric implications, such as hallucinations and
depression disorders, were observed in individuals infected with
other coronaviruses (Severance et al., 2011) and SARS-CoV-1
was indeed found in brain tissues. Neurological manifestations,
such as polyneuropathy, were assumed to be mostly due to the
cytokine flow (Stainsby et al., 2011), which often accompany
the viral damage and long-lasting hypoxia in nervous tissues
ultimately trigger neurotoxic pathways (De Chiara et al.,
2012). Similarly, both uncomplicated and severe patients with
SARS-CoV-2 may show peripheral and central nervous system
symptoms (Mao et al., 2020), and the inflammatory condition
in the most severe individuals is known to be associated
with acute delirium but also with the possible persistence of
neuropsychiatric conditions, such as stress or depression, in
those who will survive (Lam et al., 2009). Higher incidence
of swallowing disorders (Zielske et al., 2014) and aspiration
pneumonia (Prescott et al., 2015) has been reported in critically ill
survivors, thus rendering extremely important the consideration
of long-term consequences also in COVID-19 patients. The
loss of the neuronal population in critical brain areas might
underlie these conditions, which could also interest peripheral
neuromuscular districts (Tsai et al., 2004). Undeniably, this
pandemic has shocked everyone, from the infected patients and
healthcare workers to the families of the victims and those
isolated at home watching the media reporting almost one victim
of COVID-19 every 2min in Italy. The implications of the
“olfactory vector hypothesis” in a number of neurodegenerative
diseases, such as Alzheimer’s and Parkinson’s diseases, has
been presented years ago (Doty, 2008), but it should still be
worthy of consideration. Patients infected with SARS-CoV-2, if
it was able to enter the central nervous system, would easily
encounter neuronal damages over time that might contribute
to the development of neuropsychiatric disorders. If we assume
that SARS-CoV-2 could not infiltrate the brainstem, then the
neuroinflammation and hematological disruptions would still
promote both acute and chronic neuropsychiatric consequences.
Are also collateral mental conditions to be considered when
setting the mental rehabilitation paradigm. Subjects isolated
or in quarantine experience loneliness, boredom, and anger
whereas infected patients mostly experience fear (Carvalho et al.,
2020). That is, individuals may feel low, bored, frustrated,
lonely, worried for themselves of their kin, anxious, concerned
about their finances or health. On the other side, the mental
health of the hospital personnel, who is not usually used to
deal with emergencies like COVID-19, should not be neglected
as well. Long-term physical and emotional statuses were both
showed to be impaired in this population group after the
SARS-CoV-1 outbreak (Lam et al., 2009; Ngai et al., 2010).
Moreover, it was observed that these healthcare workers with
or at risk of neuropsychiatric conditions at the time of the
outbreak have been more likely to quit their job at the end of
the emergency.
DISCUSSION
The travel of SARS-CoV-2 into the human host is likely to
follow no specific route, but several in parallel. Considering
the infiltration in distinct neuroanatomical sites, we can infer a
model of symptom progression (Figure 1) that is in line with
our personal experience but also with other authors’ reports
about the early stages of the disease (Mason, 2020). The nasal
mucosa of humans seems a perfect environment for SARS-CoV-
2 proliferation making it a potential reservoir for infection, like
the salivary glands (Xu et al., 2020). A possible implication
of the glossopharyngeal and facial nerve fibers has not to be
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FIGURE 1 | The symptom progression during the invasion of the human host by the SARS-CoV-2 upon nasal (olfactory bulb) access. The severe acute respiratory
syndrome coronavirus that was discovered in Hubei province, China at the end of December 2019 (SARS-CoV-2) is a single-strand positive-sense RNA virus with the
encoding potential of four structural proteins: the spike, the envelope, the membrane, and the nucleocapsid. The human host presents many potential accesses, but
the inhalation of infected respiratory droplets exposes the airways first. (N) Assuming a nasal access, the olfactory mucosa may represent the primary site of the host
for viral proliferation. It is reasonable to believe that SARS-CoV-2 needs to replicate several times before it can reach a harmful potential to infiltrate in the olfactory bulb,
with the smell alterations being reported as one of the earliest symptoms. (O) The terminal nerve fibers extend in the olfactory epithelium colonized by the coronavirus.
Here, not only axons of the fila olfactoria can be used as routes for central access, but also the trigeminal branches, the terminal nerve, blood or lymphatic vessels, or
the cleft under the ensheathing cells of olfactory axons. (P) Upon inhalation, alveoli get in close contact with the virus, and it is reasonable to assume that the local
inflammation could affect the different nerve fiber populations comprising the neuroendocrine cells and the annexed vagal contacts. Lung infection, which might
manifest even few days after the contagion, can therefore provide direct access to the solitary tract and other parts of the central nervous system. (E) Once the virus
has been accessed the epithelial barrier of gut cells through mucus or other vector ingestion, it can colonize the intestines that are permeated with the lymphatic
system that drains the villi, the blood capillaries, and both the extrinsic and intrinsic neural networks. A fluctuating but chronic symptomatic onset is easily found. (B) It
is still not clear which is the main route for the central nervous system access that may have a critical role in SARS-CoV-2 nervous infiltration, but both the brain and
brainstem are likely to be infiltrated. High temperature is one of the earliest symptom after infection when more robust immune response is triggered, thus
subsequently being associated with a permeabilization of the blood-brain barrier and immune cell infiltration. Cardiorespiratory centers in the medulla are critical
districts that, if affected by either direct viral damages or indirect neuroinflammation and hypoxia, can lead to irreversible damage and fatal outcome.
excluded though. All three hypotheses previously advanced may
be partially true regarding the smell disorders of infected patients.
A partial nasal blockage for co-viral infections, an inflammation
of the olfactory epithelium, and a viral insult at the level
of olfactory receptor cells may all be concomitantly present.
However, some authors recently suggested that the primarily
targeted cells appear to be not the neurons, but those cells
that would have been in charge of its early airway clearance
through sputum expectoration, being the secretory and ciliated
epithelial cells (Sungnak et al., 2020). The third hypothesis
may be postponed though, thus making the hypothesis of
inflammation and mucosal swelling in the back of the nose
of primary importance (Brann et al., 2020). It is therefore
still too early to acknowledge the nasal-nervous pathway as a
potential route for host access and the local immunocompetence
of the olfactory bulb may be sufficient to block the SARS-CoV-2
entering (Durrant et al., 2016). Moreover, there are many other
neglected routes for neuroinvasion: the trigeminal nerve, the
terminal nerve, the enteric and pulmonary nervous networks,
the vagus nerve, the dorsal root ganglia, the hematogenous flow
through the circumventricular organs of the brain and brainstem,
the peripheral lymphatic vessels, the central glymphatic system,
the cerebrospinal fluid, the migrating Trojan horses, and the
conjunctiva. That is, no viral passage across the olfactory bulb
of the host has been confirmed so far and how SARS-CoV-2 gain
access to and spread in the central nervous system remains to
be explored. On the contrary, if dysosmia was an early sign of
infection it could be too late to avoid neuronal affections as viral
transport along axons is possibly moving about 2 µm/s in the
retrograde direction (Bearer et al., 2000). Because of the spatial
distribution at the level of the head, it is much more likely that
the preferred retrograde pathway is the one involving the shortest
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nerves at the level of the head, rather than the more systemic
ones, such as the vagus nerve.
Italy is one of the worst-hit countries in Europe with a
death rate of 13.9% (WHO, report of May 8th, 2020). Among
the currently infected, 72,157 are quarantined at home, 14,636
hospitalized in acute COVID-19 wards, and 1,168 hospitalized
in intensive care units. Deceased patients had a mean age of
80 years old, 60.9% were males, 60.9% had three or more
comorbid conditions (most common had been hypertension
in 68.2% and ischemic heart disease in 28.4% of cases). At
admission, the main symptoms were fever (76%), dyspnea (73%),
dry cough (38%), diarrhea (6%), and hemoptysis (1%). A mean
of 5 days passed from the onset of symptoms to hospitalization
and the other 5 days from hospitalization to death (SARS-CoV-
2 Surveillance Group of Italy, report of May 7th, 2020). Our
direct experience in managing COVID-19 patients is in line
with the abovementioned records. In addition, we observed also
dysosmia being reported by over 80% of our patients. However,
symptom reports at admission should not be taken for granted
but contextualized on the feverish subject. In fact, all patients
admitted to our hospitals are being classified as level 2 or
higher (internal classification of COVID-19 patients comprises -
level 0: asymptomatic-, -level 1: mild symptoms, pharyngodynia,
dry cough, mild fever, -level 2: moderate symptoms, high
fever, persistent cough, asthenia, dyspnea, non-invasive oxygen
therapy-, -level 3: severe symptoms, invasive oxygen therapy,
intensive care). Our infected patients were all malnourished
(Briguglio et al., 2020b) and disoriented in time and space,
thus rendering it very difficult to make an exhaustive history
about the dysfunction of the olfactory capacity and its onset
in reference to the disease. These symptoms may also derive
from excessive exposure to disinfectants due to the pandemic
(Keyhan et al., 2020), but also from medicines that are known
to interfere with the smelly sensations and the aftertaste. On
the other hand, many of our front-line colleagues infected with
SARS-CoV-2 often reported a loss of taste and smell, which
preceded the systemic symptoms, such a fever, loss of appetite,
and diarrhea. Since numerous microthrombi are also being
observed on peripheral limbs of our hospitalized patients, being
likely to occur in pulmonary and cerebral capillaries as well,
the neuronal damages should be of great concern. Other than
antibiotics, antivirals, or corticosteroids, a therapy with low-
molecular-weight heparin at daily doses over 4,000 IU should
be considered for hospitalized COVID-19 patients. Neuronal
injuries in critical brain areas of patients that will survive may
carry permanent consequences, as was observed for SARS-CoV-
1 survivors (Hui et al., 2005). Moreover, the risk of an impaired
sympatho-vagal signal is worrying since its proper functioning
is important for the peripheral immune response and central
microglial polarization (Wang et al., 2018). Some authors even
suggested that neuronal cells could serve as reservoirs for the
virus (Kabbani and Olds, 2020). To the best of our knowledge,
SARS-CoV-2 has not been found in nervous tissues so far. In
Italy, brain autopsies are currently suspended due to biohazard
security concerns (Previtali et al., 2020). However, other authors
reported the presence of the virus in the cerebrospinal fluid
(Wu et al., 2020) and others observed multiple cerebral infarcts
in vascular territories (Zhang et al., 2020). Dead-end signs of
the coronavirus cycle may reflect respiratory signs in the severe
COVID-19 host, such as ataxic breathing, altered rate and
synchrony, apnea, or hyperventilation. Overall, the survival of
the virus in the nasal cavity plus its neuroinvasive potential is
not a novel pathway of contagion among the infective agents.
This double survival in two sites of the same host permits the
virus to efficiently exploit its neurotropism while still preserving
the host-to-host transmission (MacGibeny et al., 2018). The risk
of contracting SARS-CoV-2, like any other infection, primarily
depends on the degree of exposure to the pathogen. Whether
the infected host protects himself and others from contact might
contrariwise depend on the level of awareness and, currently,
there is no recognition of smell disorders being an early symptom
of SARS-CoV-2 infection (Soler et al., 2020) nor it is established
the association between dysosmia and SARS-CoV-2 olfactory
bulb invasion. However, as the SARS-CoV-2 virus spreads, so
changed the feature of its pandemic (Brussow, 2020) and the
possibility that individuals can carry the virus without knowing
is a risk that our society cannot take. Some individuals may
show symptoms of SARS-CoV-2 infection 10 days after exposure
(Lauer et al., 2020), which is a remarkable amount of time
during which asymptomatic individuals can be carriers without
knowing. To conclude, we can say that:
• Some infected individuals show dysosmia, which may imply
nasal proliferation of SARS-CoV-2.
• Public health actions should consider smell disorders when
defining social distancing criteria.
• Axonal, trans-synaptic, blood, lymphatic, or Trojan transport
are routes for viral neuroinvasion.
• Viral access in the peripheral or central nervous system may
affect brainstem function.
• Viral neuroinvasion does not rule out long-term
neuropsychiatric consequences.
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